| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Surface Oncology, Inc. | Chief Medical Officer | Common Stock | 0 | $0.9400 | 08 Sep 2023 | Direct | |
| Surface Oncology, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 0 | 08 Sep 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123048754-oneill-alison-2023-09-08 | Surface Oncology, Inc. | 08 Sep 2023 | 2 | $0 | 4 | Chief Medical Officer | 08 Sep 2023, 17:00 |
| /report/000120919123045497-oneill-alison-2023-08-01 | Surface Oncology, Inc. | 01 Aug 2023 | 1 | -$6,619 | 4 | Chief Medical Officer | 11 Aug 2023, 20:00 |
| /report/000120919123016050-oneill-alison-2023-03-01 | Surface Oncology, Inc. | 01 Mar 2023 | 1 | $0 | 4 | Chief Medical Officer | 03 Mar 2023, 19:00 |
| /report/000120919122044674-oneill-alison-2022-08-03 | Surface Oncology, Inc. | 03 Aug 2022 | 1 | -$7,676 | 4 | Chief Medical Officer | 05 Aug 2022, 20:01 |
| /report/000120919122015963-oneill-alison-2022-03-01 | Surface Oncology, Inc. | 01 Mar 2022 | 2 | $0 | 4 | Chief Medical Officer | 03 Mar 2022, 19:00 |
| /report/000120919122003395-oneill-alison-2020-03-01 | Surface Oncology, Inc. | 01 Mar 2020 | 2 | -$90,335 | 4 | Chief Medical Officer | 14 Jan 2022, 19:30 |